The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Incidence of osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases from solid tumors or multiple myeloma: Results from three phase III trials.
Allan Lipton
Honoraria - Amgen
Research Funding - Amgen
Fred Saad
Consultant or Advisory Role - Amgen; Novartis
Honoraria - Amgen; Novartis
Research Funding - Amgen; Novartis
Catherine H. Van Poznak
Employment or Leadership Position - Bone and Cancer Foundation; Paget Foundation
Research Funding - NIH - NIDCR; Translational Breast Cancer Research Consortium
Other Remuneration - NCCN (Educational Presentation Development); School of Breast Oncology (Educational Presentation Development); UpToDate (Intellectual Property Interests); Western Michigan University School of Medicine (Educational Presentation Development)
Janet Elizabeth Brown
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Novartis
Honoraria - Amgen; Novartis
Research Funding - Novartis
Alison Stopeck
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Karim Fizazi
Consultant or Advisory Role - Amgen; Novartis
Honoraria - Amgen
David H. Henry
Consultant or Advisory Role - Amgen; Ortho Biotech; Watson Pharmaceuticals
Honoraria - Amgen; Ortho Biotech; Watson Pharmaceuticals
Research Funding - Amgen; Ortho Biotech; Watson Pharmaceuticals
Neal D. Shore
Consultant or Advisory Role - Amgen; Astellas Pharma; Bayer; Dendreon; Janssen; Medivation
Ingo J. Diel
Consultant or Advisory Role - Amgen; Novartis; Roche
Honoraria - Amgen; GlaxoSmithKline; Medtronic; Novartis; Roche; Teva
Katia Sonia Tonkin
No relevant relationships to disclose
Richard H. De Boer
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Amgen; Novartis
Other Remuneration - Amgen; Novartis
Huei Wang
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Ada H. Braun
Employment or Leadership Position - Amgen
Stock Ownership - Amgen